Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV001644779 | SCV000843538 | likely benign | not specified | 2021-01-19 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001086156 | SCV001004257 | likely benign | Spastic paraplegia | 2024-07-24 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001849074 | SCV002105051 | uncertain significance | Hereditary spastic paraplegia | 2020-01-02 | criteria provided, single submitter | clinical testing | |
Gene |
RCV002245624 | SCV002513023 | uncertain significance | not provided | 2022-04-15 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Prevention |
RCV003907976 | SCV004724828 | likely benign | SACS-related disorder | 2023-11-06 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |